K181742 is an FDA 510(k) clearance for the ReUnion Reversible Fracture System (RFX), ReUnion Reverse Shoulder Arthroplasty System (RSA), ReUnion Total Shoulder Arthroplasty System (TSA). This device is classified as a Prosthesis, Shoulder, Semi-constrained, Metal/polymer Cemented (Class II - Special Controls, product code KWS).
Submitted by Stryker GmbH (Mahwah, US). The FDA issued a Cleared decision on September 27, 2018, 87 days after receiving the submission on July 2, 2018.
This device falls under the Orthopedic FDA review panel. Regulated under 21 CFR 888.3660.